Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Cross-species comparison of AlphaFold-derived G protein-coupled receptor structures reveals novel melatonin-related receptor in Neurospora crassa

  • Cathryn S. D. Maienza,

    Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing

    Affiliation Center for Computation and Integrative Biology, Rutgers, The State of New Jersey, Camden, NJ, United States of America

  • Guillaume Lamoureux,

    Roles Conceptualization, Funding acquisition, Methodology, Writing – review & editing

    Affiliations Center for Computation and Integrative Biology, Rutgers, The State of New Jersey, Camden, NJ, United States of America, Department of Chemistry, Rutgers, The State University of New Jersey, Camden, NJ, United States of America

  • Kwangwon Lee

    Roles Conceptualization, Funding acquisition, Methodology, Project administration, Resources, Supervision, Writing – review & editing

    kwangwon.lee@rutgers.edu

    Affiliations Center for Computation and Integrative Biology, Rutgers, The State of New Jersey, Camden, NJ, United States of America, Department of Biology, Rutgers, The State University of New Jersey, Camden, NJ, United States of America

Abstract

Melatonin, a molecule with diverse biological functions, is ubiquitously present in living organisms. There is significant interest in understanding melatonin signal transduction pathways in humans, particularly due to its critical role in regulating the sleep-wake cycle. However, a knowledge gap remains in fully elucidating the mechanisms by which melatonin influences circadian regulation. To bridge this gap, there is a growing need for a model system to study the role of melatonin in circadian clocks, with Neurospora crassa being a promising candidate. As a first step in this investigation, we focused on identifying melatonin receptors in N. crassa. Given the lack of sequence similarity between potential receptors in this fungus and known human melatonin receptors, we utilized structural similarity analysis through AlphaFold2. This approach led to the identification of a strong candidate gene, gpr-3, which shares structural similarities with human melatonin receptors. Experimental validation confirmed that the removal of GPR-3 from cells results in the absence of melatonin signaling. This proof-of-concept study underscores the potential of N. crassa as a model organism for circadian research and demonstrates the broader applicability of using AlphaFold2, especially when sequence similarity does not lead to candidate genes, for identifying novel receptors across different species.

Introduction

Circadian rhythms, or biological processes that follow an endogenous 24-hour cycle, are found across all kingdoms of life, allowing organisms to adapt to daily fluctuations in external stimuli. Time-of-day cues called “zeitgebers” cause expressional and posttranslational alterations to genes comprising an organism’s molecular clock, thus entraining, or syncing, the clock to external conditions [13]. Although the genes involved differ on a species level, the general mechanistic composition of the molecular clock, or circadian oscillator, is conserved across vertebrates, invertebrates, and fungi: a positive element promotes the expression of a negative element, which accumulates and undergoes posttranslational modifications eventually forming a complex which represses expression of the negative element. The cycle starts anew when the negative element reaches a specific level of phosphorylation and/or is degraded, and expressional repression is relieved [47]. This conserved transcriptional-translational feedback oscillator (TTFO) allows for experimental comparisons between species of molecular responses to zeitgebers, as has been done for decades in the field of chronobiology using the filamentous fungi Neurospora crassa and mammalian systems.

Although TTFO entrainment to classic zeitgebers like light and temperature have been widely studied and are well categorized in model organisms across kingdoms [811], the same cannot be said of the hormonal zeitgeber known as melatonin. Melatonin is a widely conserved molecule derived from the tryptophan/serotonin biosynthesis pathway and enzymes which catalyze its biosynthesis like serotonin N-acetyltransferase (AANAT) and N-acetylserotonin O-methyltransferase (ASMT) have been found in animals, plants, fungi, and bacteria [12,13]. Most of what is known about melatonin has come from vertebrate systems, focusing on its pharmacological properties in humans. Melatonin has therapeutic effects for a wide range of physiological processes including detoxification of free radicals, cardiovascular health, fetal development, and tumor suppression [14,15]. The hormone is known for its role in sleep regulation, acting as an endogenous zeitgeber synthesized and secreted into the circulatory system from the pineal gland during subjective night [15,16]. Secretion of melatonin in animals adheres to a circadian rhythm: levels of melatonin detectable through blood and saliva begin to rise at the onset of subjective night, peaking at midnight before gradually returning to basal levels early in the subjective morning [17]. Despite a sparsity of research done in Neurospora regarding melatonin, the hormone was found to follow a similar secretion pattern into surrounding liquid media in cycling and constant photoperiodic conditions [12].

In mammalian systems, melatonin has been found to alter the amplitude and rhythmicity of gene expression within the TTFO. The positive elements Bmal1 and Clock (Clk) and negative elements Per and Cry appear to have tissue-specific expression responses to melatonin treatment, generally manifesting as reduced expression of one gene, usually Per, or combinations of them [15,18]. It is currently believed the observed changes in the TTFO in response to melatonin are due to suppression of the highly conserved cAMP/PKA signaling pathway and of cAMP-responsive element (CRE)-binding protein (CREB), a known regulatory element of Per, recruiting the positive elements BMAL1 and CLK consequently promoting Per expression [19,20]. Although nothing is known of melatonin signaling in Neurospora, PKA is known to post-translationally-modify the positive element White Collar 1 (WC-1) leading to destabilization of the protein and expressional inhibition of the negative element frequency (frq). PKA is also able to phosphorylate FRQ protein, in this case stabilizing the core clock element and slowing its degradation [21,22]. Given the existence of a conserved cAMP-dependent kinase able to alter expression of core clock elements of the TTFO in both mammals and Neurospora, a conserved mechanism for melatonin signaling is possible.

Decreased cellular cAMP concentration in response to melatonin is attributed to the activity of two Class A/Rhodopsin Family G protein-coupled (GPCR) melatonin receptors, MT1 and MT2, whose Gαi subunits inhibit the activity of adenylyl cyclase (AC) and production of cAMP [23]. In recent years, much research has been done on the protein-protein interactions between MT1 and MT2, as the receptors are often found as hetero- or homodimers with themselves, or other melatonin-related GPCRs like GPR50 that otherwise do not bind directly with the hormone [24]. Understanding how MT1 and MT2 interact is a crucial advancement for pharmacology, given that the receptors have different downstream signaling pathways depending on their dimerization and tissue of origin [23]. Finding one, potentially multiple, melatonin receptors in a genetically simple, yet orthologous, eukaryotic model system like Neurospora would increase the efficiency by which these hetero-/homodimer dynamics are studied experimentally.

Melatonin receptors have been found in complex eukaryotic organisms such as nonmammalian vertebrates, invertebrates, and plants [13]. However, attempting to identify orthologous receptors between kingdoms through primary protein sequence proves challenging. While vertebrate melatonin receptors are similar enough to appear with high percentage identity in a BLASTP search, known plant and invertebrate receptors align poorly with MT1 and MT2. When compared to the plant melatonin receptor PMTR-1 found in Arabidopsis thaliana (AN: Q94AH1.1), human MT1 (AN: NP_005949.1) aligns with only 21% coverage and roughly 32% percent identity [25]. The sequence for AccMTNR1A (AN: ASN64549.1), a melatonin receptor found in the honeybee species Apis cerana cerana, is too dissimilar in sequence to align with MT1 [26]. Interestingly, despite low sequence homology, nearly all melatonin-binding receptors are transmembrane GPCRs, suggesting conservation of structure and function rather than primary amino acid sequence. Given the widespread conservation of melatonin, it is possible that the primary sequence of MT1 and orthologous proteins were allowed to diverge during evolution, so long as the ligand-binding pocket remained compatible with melatonin. Alternatively, the lack of sequence homology in melatonin receptors could be the result of convergent evolution, such that a receptor for melatonin arose independently in different kingdoms. For this reason, we reasoned that structural comparisons of MT1 to GPCRs with unknown functions could prove invaluable for identifying novel melatonin receptors across kingdoms.

In this study, we aim to identify a novel melatonin receptor in N. crassa by comparing structures of human of MT1 and MT2 with the 43 known fungal GPCRs, some of which have unknown functions [27]. Traditionally costly and time-consuming structural protein analyses have been made more accessible by AI-based programs such as Google DeepMind’s AlphaFold [28] used in combination with publicly available alignment tools like Dali protein alignment [29] and the more recent Foldseek [30]. Through this methodology, we identified a group of fungal GPCRs that form a sister clade with MT1 and MT2 based on their structural similarity, focusing on a functionally uncharacterized fungal receptor, gpr-3. We found that genetic knockouts of gpr-3 are insensitive to treatment with melatonin when compared to the wild type, supporting our hypothesis that gpr-3 is a novel melatonin-related receptor in fungi. This study represents the first identification of a melatonin-related receptor in fungi as far as the authors’ knowledge and proposes AlphaFold2/Dali structural comparisons as a powerful tool for hypothesis generation when attempting to identify orthologous proteins in other model organisms.

Results

Alphafold2/Dali structural alignment for human GPCRs recapitulates class relationships

As proof of concept and to test AlphaFold2’s accuracy with GPCR structural predictions, 51 human GPCRs from each of the five recognized GPCR classes were randomly sampled relative to class size (Methods). Each of the five classes are established based off structural similarities and ligand-binding capabilities possessed by its protein family, therefore providing a good test sample for AlphaFold2’s ability to predict functionally relevant structures [31,32]. The AlphaFold-predicted structures of the sample set were aligned using Dali All Against All to visualize their structural relatedness (Fig 1). With few exceptions, the GPCR’s were grouped together into clades with their respective family members, in many cases recapitulating the specific phylogenetic relationships determined through sequence analysis [31]. Similarities to previously determined phylogenies often have minor inconsistencies, such as the individual relationships for HTR1B/D/A and DRD1/2/3 in Class A matching the sequence phylogeny but disagreeing with each group’s proposed relationship to CHRM1/2/3. Nonetheless, the relationships of GPCRs most closely related to MT1 and MT2 as determined by structure, such as GPR50, OPN3, RHO, and OPN1LW/MW, were identical to those proposed by sequence alignment. Interestingly, GPR50 which itself cannot bind to melatonin yet interacts with MT1 forms a sister clade with MT1 and MT2, hinting at their related function albeit different ligand binding capabilities. The resulting similarities between previous literature and our AlphaFold2-derived structural phylogeny provided a sound framework for which to continue structural comparisons of MT1 and MT2 with fungal GPCRs.

thumbnail
Fig 1. Dendrogram of structural relatedness for 51 human GPCRs including MT1/MT2.

FASTA protein sequences for 51 randomly sampled GPCRs were structurally predicted using AlphaFold2 and compared using Dali All Against All. MT1/MT2 outlined in red. Color boxes denote GPCR class: Class A/Rhodopsin (blue), Class B/Secretin (red), Class C/Glutamate (yellow), Class F/Frizzled/Taste (green), Class Adhesion (purple), other (no color). Dendrogram formatted using Phylo.io.

https://doi.org/10.1371/journal.pone.0318362.g001

Alphafold2/Dali structural comparison reveals fungal sister clade to MT1/MT2

To identify fungal GPCRs structurally like human MT1/MT2, structural predictions were generated with AlphaFold2 for the 43 GPCRs in N. crassa (detailed in Cecon et al., 2018) and MT1/MT2. The proteins were structurally aligned using Dali All Against All to produce a dendrogram (Fig 2). A group of four fungal GPCRs, GPR-1-4, were most closely related to the structures of MT1/MT2 forming a sister clade to the human receptors. GPR-1-3 are members of the “cAMP receptor-like” Class V GPCR family while GPR-4 is a “carbon sensory” Class III GPCR in N. crassa; the grouping of these GPCRs in relation to GPCR Class is recapitulated in the dendrogram, as GPR-1-3 are more alike than any are to GPR-4. The functions of GPR-1 and GPR-4 have been experimentally confirmed: gpr-1 mutants exhibit abnormal female sexual reproductive organ development and gpr-4 mutants struggle to adapt to different carbon sources [33,34]. The remaining two proteins, GPR-2 and GPR-3, have no known functions and have relatively similar similarity scores to MT1 (Z-score and %ID for GPR-2: 23.3 and 12%, for GPR-3: 21.1 and 14%). We chose to focus on one receptor, GPR-3, for further experimental validation of melatonin sensitivity. Dali pairwise alignments of GPR-3 to MT1/MT2 highlight structural equivalency of amino acid positions in GPR-3 relevant to the ligand-binding pocket in MT1/MT2, such as the YPYP motif (Y79-P82) and C177/F179 found within extracellular loop 2 (ECL2) (S2 Fig) [35].

thumbnail
Fig 2. Dendrogram of structural relatedness between 43 fungal GPCRs and MT1/MT2.

FASTA protein sequences for the 43 identified fungal GPCRs and human MT1/MT2 were structurally predicted using AlphaFold2 and compared using Dali All Against All. A sister clade is formed with four fungal GPCRs, GPR-1-4, marked with a green box. The clade containing MT1/MT2 is shown with a red box. Roman numerals indicate which of the 14 fungal GPCR class each GPCR falls into as outlined in Cabrera et al., 2015. Dendrogram formatted using Phylo.io.

https://doi.org/10.1371/journal.pone.0318362.g002

Knockouts of gpr-3 lack FRQ phase shift in response to melatonin

While our AlphaFold2/Dali approach provided us with the candidate gene gpr-3, experimental validations of melatonin-insensitivity phenotypes in Neurospora strains lacking gpr-3 were conducted to test our hypothesis of GPR-3 as a fungal melatonin-related receptor. In mammalian systems, melatonin affects the relative abundance of key clock elements downstream of the melatonin signaling pathway [19,20]. To test this in Neurospora, we used a luciferase translational reporter of the negative clock element FRQ (FRQ::LUC) to measure changes in FRQ oscillation rates following treatment with 5 ng/mL melatonin in constant dark conditions (Fig 3).

thumbnail
Fig 3. Genetic knockouts of gpr-3 are insensitive to melatonin-induced phase shifts of TTFO negative element FRQ.

Difference in FRQ::LUC between gpr-3- (N380-2, n = 3) and gpr-3+ (N380-1, n = 3) strains of Neurospora crassa two hours after treatment with 5ng/mL melatonin in 1x fructose/glucose/sorbose media (FGS). Control group was treated with sterile water. Two-way ANOVA revealed significant effect of melatonin treatment on N380-1 (p = 0.02) but not in the strain lacking gpr-3 (p = 0.07). FRQ::LUC–luciferase translational reporter for key clock component Frequency, *–p<0.05, ns–not significant.

https://doi.org/10.1371/journal.pone.0318362.g003

FRQ::LUC levels provide a reliable proxy for circadian time (CT), where CT0/24 corresponds to the minimum FRQ level at the start of the subjective day, and CT12 represents the maximum level at the start of the subjective night. This allows visualization of phase shifts or resetting of the circadian TTFO by external stimuli, also known as zeitgebers, such as melatonin [36,37].

Under constant dark conditions, FRQ levels naturally decline at CT18, serving as a baseline. This expected oscillation pattern was observed in both wild-type (N380-1) and gpr-3 knockout (N380-2) strains; however, the rate of decline was less robust in N380-2. Following melatonin treatment, the wild-type strain N380-1 exhibited a significant reduction in the rate of FRQ oscillation (two-way ANOVA, p = 0.02), supporting the hypothesis that melatonin influences TTFO elements in Neurospora. This response was absent in the knockout strain N380-2, as the rate of FRQ decline did not significantly differ after melatonin treatment. These findings suggest that GPR-3 plays an essential role in mediating melatonin signaling pathways in Neurospora.

Knockouts of gpr-3 exhibit reduced sensitivity to melatonin-induced cAMP fluctuations

The binding of melatonin to MT1 or MT2 results in an overall decrease in cAMP concentration in mammalian cells [20,23]. In a preliminary study examining the effects of a range of melatonin concentrations on cAMP levels in our wild type, we observed robust declines in cellular cAMP levels from concentrations as high as 50μg/mL to the physiologically relevant range of 5ng/mL of melatonin (S1 Fig). Therefore, to test gpr-3 as a melatonin-related receptor we measured changes in cAMP levels after treatment with physiologically relevant concentrations of melatonin in a gpr-3- knockout (N380-2), its wild type sister strain (N380-1), and a knockout of the Gαi subunit gna-1. In mammalian melatonin receptors the Gαi subunit of MT1/MT2 inhibits cAMP production [23], leading us to hypothesize a conserved G-protein preference for receptor-mediated melatonin signaling in Neurospora. Previous research has found that one of the three fungal Gαi subunits, gna-1, acts downstream of gpr-1 and gpr-4 [33,34], thus we used gna-1 as a negative control. Samples of the three strains were entrained to cycling conditions (LD 12:12) before treatment at zeitgeber time 18 (ZT18) with a 5ng/mL melatonin solution for 10 minutes and assayed for changes in relative cAMP levels (Fig 4). After treatment with melatonin, the gpr+ strain N380-1 experienced a decrease in cellular cAMP averaging around a 26 nM, with a maximum observed decrease of up to 60 nM. The decrease in cAMP concentration seen in N380-1 is consistent with what is known about human MT1 and MT2, suggesting a conserved signaling molecule pathway. The gpr-3- strain N380-2 showed an average increase in cAMP levels of approximately 0.25nM while gna-1 exhibited an average decrease of 8.74nM, compared to the control strain N380-1. Interestingly, fluctuations in cellular cAMP levels were only significantly different between the sister strains N380-1 and N380-2 (one-way ANOVA, p = 0.036). Despite the cAMP assay results from gna-1 lacking a statistical difference from those of N380-1 and N380-2, melatonin-induced alterations in cellular concentration of cAMP were clearly observed in the wild type yet not in strains lacking gpr-3, and to a lesser extent in gna-1. These findings support our hypothesis that gpr-3 is involved in the melatonin signaling response in Neurospora and the cAMP signaling pathway is a conserved downstream mechanism of receptor-mediated responses to melatonin.

thumbnail
Fig 4. Knockouts of gpr-3 lack cAMP signaling response to melatonin.

Difference in relative cAMP concentration between gpr-3+ (N380-1, n = 6), gpr-3- (N380-2, n = 6), and gna-1-(n = 6) strains after 10-minute treatment with 5ng/mL melatonin in sterile water. Untreated group was treated only with water. One-way ANOVA revealed statistically significant decrease of cAMP in response to melatonin treatment in N380-1 when compared to N380-2 (p = 0.036). There was no significant difference between N380-1 or N380-2 with gna-1 (p = 0.204, p = 0.607, respectfully. nd–no difference, *–p<0.05.

https://doi.org/10.1371/journal.pone.0318362.g004

Discussion

Through the combined application of AlphaFold2 and Dali, we conducted a cross-species structural comparison of human melatonin receptors MT1 and MT2 to all 43 fungal GPCRs identified in N. crassa, hypothesizing that a novel fungal melatonin receptor would have a conserved tertiary structure to those found in mammals. We identified a group of four fungal receptors, GPR-1-4, which formed a sister clade with MT1/MT2 and used further experimental tests to validate one protein, GPR-3, as a candidate melatonin-related receptor in Neurospora. Knockout strains of gpr-3 exhibited an insensitivity to melatonin-induced phase shifts in the natural oscillation of FRQ, the negative regulatory element of the Neurospora TTFO. By assaying cAMP levels after treatment with melatonin, we observed significant reductions in cellular cAMP concentrations in our wild type but not in strains lacking gpr-3. Collectively our findings support our hypothesis that Neurospora possess a melatonin-sensitive GPCR structurally similar to MT1/MT2 and present Neurospora as a useful model for future research into the genetic conservation of the melatonin signaling pathway across eukaryotes.

Structural and comparative genomics are valuable tools for a wide variety of biological fields, particularly in understanding disease evolution and progressing advancements in pharmacology [38,39]. With the advent of AlphaFold and its ability to predict protein structures with high efficiency and accuracy, combining structural and comparative genomics such as we did through our use of two free-to-use programs, AlphaFold2 and Dali, is more accessible than ever. Our work shows the power of this methodology to identify potential orthologs to human melatonin receptors in N. crassa, thus providing a simple eukaryotic model organism for melatonin pharmacology. Although the identification of a fungal melatonin receptor was the focal point of our study, the combined application of AlphaFold2/Dali could be further utilized to research GPCRs in humans and Neurospora. For example, there remain “orphan” GPCRs with unknown ligands in many eukaryotic organisms like mammals and fungi, whose functions could be hypothesized through a similar methodology to ours [40]. Our approach also provides insights for molecular evolution: cross-referencing previously determined GPCR class relationships in humans based on sequence alignments [31] with phylogenies derived from AlphaFold2/Dali adds an additional layer of understanding to the evolution of GPCRs in eukaryotes. Our unique approach to structural and comparative genomics is applicable to many biological questions and when used in conjunction with experimental validation is a powerful tool for hypothesis generation.

This study was validated experimentally through FRQ::LUC and cAMP level assays in gpr-3- strains, providing the first evidence of a novel melatonin-related receptor in N. crassa. Given the seemingly conserved, circadian secretion of humoral melatonin between N. crassa and humans [12,17], we hypothesize that much of the molecular mechanisms of melatonin are conserved between them, and potentially all eukaryotes. Many questions do remain regarding the entire Neurospora TTFO response to melatonin and the specifics of the gpr-3-mediated melatonin signaling pathway. We currently suspect PKA as a potential bridge between the cAMP signaling pathway and the TTFO in Neurospora, as has been proposed in mammals [19,20]. We witnessed a significant decrease in the natural decline of FRQ protein in response to melatonin. In mammals, it has been observed that expression of the negative element Per and sometimes Cry decreases after treatment with melatonin [15], potentially hinting at a conserved mechanism of modulating a negative TTFO element. Future examinations of the relative transcript and protein levels of key clock elements WC-1, WC-2, and FRQ in response to melatonin would provide valuable insights into the receptor-mediated zeitgeber response to the hormone in Neurospora.

Regarding a conserved cAMP signaling response downstream of GPR-3, our wild type exhibited a significant decrease in cellular cAMP after melatonin treatment that was not observed in gpr-3 knockouts, supporting our hypothesis that GPR-3 is a melatonin-related receptor in Neurospora. Interestingly, our negative control, gna-1, was not significantly different from the wild type or knockout though still experiencing a markedly reduced response to melatonin. Given that there are three Gαi genes in Neurospora, it is possible that gna-2 or gna-3 are the preferential G-protein for GPR-3 [41,42]. However, this result could also highlight a difference in the pharmacological profile of GPR-3 to MT1/MT2. It is widely observed that the preferred G-protein subunit for both human melatonin receptors is Gαi, though MT1 has been found to couple with Gq/11 and Gs subunits [43,44]. While our findings revealed a shared response to melatonin between GPR-3 and MT1/MT2, namely a marked decrease in cellular cAMP levels, more research is needed to fully characterize GPR-3 as an authentic MT1/MT2 ortholog. Further research into the preferred subunit of GPR-3, as well as an examination of cAMP synthesis and signaling in response to melatonin through GPR-3 will add to our comprehension of GPR-3’s species-specific pharmacological behavior.

In the current study, we presented a single candidate melatonin-related receptor in Neurospora, namely GPR-3. However, a question we are working on is whether Neurospora possess multiple melatonin receptors, as is observed in vertebrates. We did not study GPR-2, the other fungal GPCR with unknown functions, yet it remains a protein of interest given its structural similarity to MT1/MT2. We also do not rule out the possibility of multiple functions in GPR-1 and GPR-4 and are currently working to characterize the melatonin response in single and multi-knockouts of each gene. For example, though previous studies have not found shared functions between these proteins, it has been proposed in the case of GPR-1, a protein required for proper female reproductive organ development, that G-protein-independent functions may exist [33]. It is possible that like human GPR50, one of the other three fungal GPCRs could lack the ability to bind to melatonin but interact with and inhibit an authentic melatonin receptor [23]. Given that the multiple melatonin receptors in mammals can interact with one another and experience differential preferences in G-protein subunit binding, there are many useful applications for a simple model organism with orthologous proteins to MT1, MT2 and GPR50. Identifying multiple melatonin-related receptors in both mammals and fungi would also support the idea that other eukaryotes such as plants and insects also possess yet to be identified receptors that could be found through a similar methodology to our own.

By adopting a structural and comparative approach through the combined use of AlphaFold2 and Dali, we identified a GPCR in N. crassa, GPR-3, that is structurally like human MT1 and MT2. Experimental validation of sensitivity to melatonin in knockouts of gpr-3 show reduced downstream responses to the hormone in FRQ oscillation rates and intracellular cAMP levels, supporting our hypothesis of GPR-3 as the first melatonin-related receptor to be identified in N. crassa. Our innovative approach to finding orthologous proteins across kingdoms presents an easily accessible methodology that could hasten the identification of pharmacologically relevant proteins in other model organisms.

Materials and methods

Structural comparison of pharmacologically relevant human GPCRs using AlphaFold2/Dali

A list of 500 human GPCRs were obtained from the IUPHAR/BPS Guide to Pharmacology database and randomly sampled, with specific inclusion of MT1 and MT2, relative to Class size [45]. 51 human GPCR’s were sampled in total from the 6 classes: 24 from Class A/Rhodopsin Family, 11 from Class B/Secretin Family, 1 from Class B/Adhesion Family, 3 from Class C/Glutamate Family, 6 from Class F/Frizzled Family, and 4 categorized as Other TM7 proteins. Class B/Adhesion and Class C/Glutamate had disparate sampling size due larger size (1,500+ aa) of GPCR’s in these classes; large proteins have low confidence scores in AlphaFold. FASTA files for the individual protein sequences were compiled and run through AlphaFold2 ColabFold BATCH with standard settings [46]. The models with the highest confidence (pLDDT score closest to 100) were then structurally aligned using Dali all against all comparison [29]. The dendrogram produced by Dali was saved as a phyloxml file and formatted using Phylo.io.

Structural comparison of fungal GPCRs to MT1/MT2 using AlphaFold2/Dali

FASTA files with protein sequences for the 43 fungal GPCRs were obtained through FungiDB based off provided accession numbers [27]. Protein sequences for MT1 and MT2 were obtained through NCBI (MT1: NP_005949.1, MT2: NP_005950.1). All 45 FASTA files were input into ColabFold BATCH with standard settings [46]. For each protein, the output pdb file with the highest confidence score (pLDDT) was then input into the Dali All Against All alignment program. The dendrogram produced by Dali was saved as a phyloxml file and formatted using Phylo.io. Acquisition of individual similarity values for GPR-2 and GPR-3 against MT1 was done through Dali’s pairwise structure comparison.

N. crassa strains used

A knockout of gpr-3 (NCU09427) was obtained from the Fungal Genetics Stock Center (FGSC) Department of Microbiology, University of Kansas Medical Center, Kansas City Kansas. This strain was crossed with the FRQ::LUCbd- bearing strain L4 (X716-4A) to create a gpr-3-;FRQ::LUCbd- strain referred to as N380. X716-4A was a gift from Dr. Luis Larrondo at Pontificia Universidad Católica de Chile. From this cross, a “wild type” gpr-3+;FRQ::LUCbd- strain and its knockout (gpr-3-;FRQ::LUCbd-) sister strain (N380-1 and N380-2, respectively) were used for the experimental portions of this study. For the cAMP assays, a knockout of the fungal Gαi, gna-1 (NCU06493) from FGSC was used as a negative control.

Growth and circadian entrainment of samples

For use in the cAMP assay, N380-1, N380-2 and gna-1 were cultured in 200ml flasks containing agar complete medium. The samples were incubated at 30°C for 24 hours and then transferred to a growing chamber set to 25°C with equinox photoperiodic conditions (LD 12:12). Samples were allowed to entrain for 5 days before being removed for preparation at zeitgeber time (ZT) 12. Samples of N380-1 and N380-2 used for the melatonin-induced phase shift luciferase assay experiment were cultured on minimal media slants for five days in LD 12:12 at 25°C.

Preparations of melatonin solution and cAMP-GloTM reagents

Physiologically relevant ranges of melatonin found in liquid cultures of N. crassa are between 1-3ng/mL [12]. For this study, a melatonin solution of 5ng/ml in sterile water was prepared via serial 10-fold dilutions from a 1mg/20mL stock solution (prepared with 100% ethanol). Samples were prepared the day of the experiment and the same sterile water for the solution was used as a control. All reagents for the cAMP-GloTM kit were prepared and stored in accordance with the provided protocol for the 96-well format.

FRQ::LUC microplate assay for melatonin-induced phase shifts

Five-day-old cultures of N380-1 and N380-2 were used to make 1mL conidia suspensions in sterile water. 125μL of each conidia suspension was added to 5mL 1x sorbose/glucose/fructose liquid media (1% sorbose, 0.05% glucose/fructose, FGS) along with 200μL of 1000X biotin solution and 200μL of 10mM D-luciferin (dissolved in sterile water). The plating mixtures were vortexted and 200μL of each suspension were aliquoted into 12 wells. A sterile microplate film was applied to minimize evaporation, and a sterile needle was used to create small holes for gas exchange over each well. The microplate was put into LD12:12 conditions at 25°C for one day to colonize before being put into a luminometer in constant darkness at 25°C. The luminometer firefly luciferase program was set to cycle a max length kinetic read twice (100 hours single, 200 hours total) at one-hour intervals. All strains contained a translational reporter of the negative element Frequency (FRQ) in the form of a FRQ::Luciferase (FRQ::LUC) fusion protein [47]. The levels of FRQ were monitored to observe when amounts of FRQ reached their peak (~CT12). Six hours after this peak (~CT18) the program was interrupted under red light and 3 wells from each strain were spiked with either 10μL of 5ng/mL melatonin in sterile water for the test group, or 10μL of sterile water for the control. CT18 (and ZT18 for cAMP assay) were selected as time of treatment due to significant circadian phase shifts observed on human melatonin phase response curves, and we hypothesized any cellular effects of melatonin would be most pronounced at this time [17,48]. Two hours after treatment, luminescence was recorded for each of the samples and used to calculate percent difference in FRQ levels from the reading immediately before interruption: (relative luminescence reading at 0 hr /relative luminescence reading at 2 hr) x100.

Preparation of samples for cAMP-GloTM assay

To measure changes in cAMP concentration in response to melatonin, the Promega cAMP-GloTM Assay was used [49]. The assay is designed for mammalian cells but was successfully adapted for fungi in a previous study and works like a cell suspension in the assay protocol [50]. Methodology from previous literature was slightly altered in the present study for use with N. crassa. Cultures of N380-1, N380-2, and gna-1 were removed from LD12:12 conditions at ZT12. Under red light, a conidia suspension was made for each sample by adding 25mL of high glucose liquid medium (HGM, 2% D-glucose, 0.5% L-arginine, 1X Vogel’s salts) to the culture flasks and vortexing for 30 seconds. The suspension was filtered through a single layer of miracloth into centrifuge tubes. Cell counts were taken, and suspensions were diluted with HGM until all cell counts were roughly around 1.0x107 cells/mL. In constant darkness and while nutating, the conidia suspensions were left to culture until ZT18 to normalize cell age. At ZT18, 10ml of the suspension was aliquoted into separate tubes and treated with 1ml of 5ng/mL melatonin solution or sterile water as a control and nutated for 10 minutes at room temperature in constant darkness. The samples were spun at 2000rpm, 4°C for 10 minutes. Pellets were dried and resuspended in 1.5mL of ice-cold sterile water and spun again for 7 minutes at the same settings. The pellets were dried again and 500mg of zirconia silica beads and 1mL ice-cold 10% TCA were added to the tubes. The samples were beat for 15 minutes in an ice-cold beater at max speed and then spun for 7 minutes at 3000rpm. The liquid layer was removed and washed in glass test tubes twice with water-saturated ether. Following the cAMP-GloTM assay protocol for recommended test compound volumes for cell suspensions in a 96-well plate, 10μL of the aqueous layer was used in each test well. Each strain and treatment group had 6 technical replicates. From this point forward, the cAMP-GloTM protocol was followed for the 96-well assay format.

Supporting information

S1 Fig. Decrease of cellular cAMP levels in response to a concentration range of melatonin treatments.

Melatonin was dissolved in HGM and serially diluted. Control was treated with HGM containing no melatonin. **—p<0.005, ***—p<0.0005.

https://doi.org/10.1371/journal.pone.0318362.s001

(TIFF)

S2 Fig.

Dali structural alignment of N. crassa GPR-3 to MT1(left) and MT2 (right). Uppercase letters denote structurally equivalent positions, vertical lines denote equivalent amino acid positions. Query–GPR-3, Subject–MT1 or MT2, DSSP abbreviations–H(helix), L(loop), E(coil). Z-score = 21.1, 20.5, respectively.

https://doi.org/10.1371/journal.pone.0318362.s002

(TIFF)

Acknowledgments

We would like to acknowledge Drs. Siddharth Bhadra-Lobo and Charot Rodeget for insightful suggestions. We would also like to thank Dr. Katherine Borkovich for her insights on GPR-1-4 as well as suggestions for the cAMP Glo assays.

References

  1. 1. Aschoff J, Pohl H. Phase relations between a circadian rhythm and its zeitgeber within the range of entrainment. Naturwissenschaften. 1978;65(2):80–4. pmid:345129
  2. 2. Dunlap JC, Loros JJ. Making Time: Conservation of Biological Clocks from Fungi to Animals 2018.
  3. 3. Schibler U. Heartfelt enlightenment. Nature. 2000;404(6773):25–7. pmid:10716426
  4. 4. Hurley JM, Loros JJ, Dunlap JC. Circadian Oscillators: Around the Transcription-Translation Feedback Loop and on to Output. Trends in Biochemical Sciences. 2016;41(10):834–46. WOS:000384943000006. pmid:27498225
  5. 5. Dunlap JC. Common threads in eukaryotic circadian systems. Curr Opin Genet Dev. 1998;8(4):400–6. pmid:9729714.
  6. 6. Dunlap JC, Loros JJ, Liu Y, Crosthwaite SK. Eukaryotic circadian systems: cycles in common. Genes to Cells. 1999;4(1):01–10. pmid:10231388
  7. 7. Bell-Pedersen D, Cassone VM, Earnest DJ, Golden SS, Hardin PE, Thomas TL, et al. Circadian rhythms from multiple oscillators: lessons from diverse organisms. Nat Rev Genet. 2005;6(7):544–56. pmid:15951747; PubMed Central PMCID: PMC2735866.
  8. 8. Merrow M, Roenneberg T. Circadian entrainment of Neurospora crassa. Cold Spring Harb Symp Quant Biol. 2007;72:279–85. pmid:18419284.
  9. 9. Burt P, Grabe S, Madeti C, Upadhyay A, Merrow M, Roenneberg T, et al. Principles underlying the complex dynamics of temperature entrainment by a circadian clock. iScience. 2021;24(11):103370. pmid:34816105
  10. 10. Avello PA, Davis SJ, Ronald J, Pitchford JW. Heat the Clock: Entrainment and Compensation in Arabidopsis Circadian Rhythms. Journal of Circadian Rhythms. 2019. pmid:31139231
  11. 11. Foster R. Fundamentals of circadian entrainment by light. Lighting Research & Technology. 2021;53(5):377–93.
  12. 12. Balzer I, Höcker B, Kapp H, Bartolomaeus B. Occurrence and comparative physiology of melatonin in evolutionary diverse organisms. In: Driessche TV, Guisset J-L, Petiau-de Vries GM, editors. The Redox State and Circadian Rhythms. Dordrecht: Springer Netherlands; 2000. p. 95–119.
  13. 13. Zhao D, Yu Y, Shen Y, Liu Q, Zhao ZW, Sharma R, et al. Melatonin Synthesis and Function: Evolutionary History in Animals and Plants. Frontiers in Endocrinology. 2019;10. WOS:000464946200002. pmid:31057485
  14. 14. Tordjman S, Chokron S, Delorme R, Charrier A, Bellissant E, Jaafari N, et al. Melatonin: Pharmacology, Functions and Therapeutic Benefits. Curr Neuropharmacol. 2017;15(3):434–43. pmid:28503116; PubMed Central PMCID: PMC5405617.
  15. 15. Hardeland R, Madrid JA, Tan DX, Reiter RJ. Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signaling. J Pineal Res. 2012;52(2):139–66. Epub 20111028. pmid:22034907.
  16. 16. Schomerus C, Korf HW. Mechanisms regulating melatonin synthesis in the mammalian pineal organ. Ann N Y Acad Sci. 2005;1057:372–83. pmid:16399907.
  17. 17. Benloucif S, Burgess HJ, Klerman EB, Lewy AJ, Middleton B, Murphy PJ, et al. Measuring melatonin in humans. J Clin Sleep Med. 2008;4(1):66–9. pmid:18350967; PubMed Central PMCID: PMC2276833.
  18. 18. Partch CL, Green CB, Takahashi JS. Molecular architecture of the mammalian circadian clock. Trends Cell Biol. 2014;24(2):90–9. Epub 20130801. pmid:23916625; PubMed Central PMCID: PMC3946763.
  19. 19. Travnickova-Bendova Z, Cermakian N, Reppert SM, Sassone-Corsi P. Bimodal regulation of mPeriod promoters by CREB-dependent signaling and CLOCK/BMAL1 activity. Proc Natl Acad Sci U S A. 2002;99(11):7728–33. pmid:12032351; PubMed Central PMCID: PMC124335.
  20. 20. Zhao SQ, Gao Y, Zhang Y, Yang XP, Yang Z. cAMP/PKA/CREB signaling pathway-mediated effects of melatonin receptor genes on clock gene expression in Bactrian camel ovarian granulosa cells. Domest Anim Endocrinol. 2021;76:106609. Epub 20210129. pmid:33636446.
  21. 21. Froehlich AC, Pregueiro A, Lee K, Denault D, Colot H, Nowrousian M, et al. The molecular workings of the Neurospora biological clock. Novartis Found Symp. 2003;253:184–98; discussion 02–9, 98–202, 81–4. pmid:14712922.
  22. 22. Huang G, Chen S, Li S, Cha J, Long C, Li L, et al. Protein kinase A and casein kinases mediate sequential phosphorylation events in the circadian negative feedback loop. Genes Dev. 2007;21(24):3283–95. pmid:18079175; PubMed Central PMCID: PMC2113029.
  23. 23. Cecon E, Oishi A, Jockers R. Melatonin receptors: molecular pharmacology and signalling in the context of system bias. British Journal of Pharmacology. 2018;175(16):3263–80. WOS:000439750500009. pmid:28707298
  24. 24. Tse LH, Wong YH. Modeling the Heterodimer Interfaces of Melatonin Receptors. Front Cell Neurosci. 2021;15:725296. Epub 20211007. pmid:34690701; PubMed Central PMCID: PMC8529217.
  25. 25. Wei J, Li DX, Zhang JR, Shan C, Rengel Z, Song ZB, et al. Phytomelatonin receptor PMTR1-mediated signaling regulates stomatal closure in Arabidopsis thaliana. Journal of Pineal Research. 2018;65(2). WOS:000441133600010. pmid:29702752
  26. 26. Li G, Zhang Y, Ni Y, Wang Y, Xu B, Guo X. Identification of a melatonin receptor type 1A gene (AccMTNR1A) in Apis cerana cerana and its possible involvement in the response to low temperature stress. Naturwissenschaften. 2018;105(3–4):24. Epub 20180322. pmid:29569081.
  27. 27. Cabrera IE, Pacentine IV, Lim A, Guerrero N, Krystofova S, Li LD, et al. Global Analysis of Predicted G Protein-Coupled Receptor Genes in the Filamentous Fungus, Neurospora crassa. G3-Genes Genomes Genetics. 2015;5(12):2729–43. WOS:000367257500022. pmid:26464358
  28. 28. Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596(7873):583–9. pmid:34265844
  29. 29. Holm L. Dali server: structural unification of protein families. Nucleic Acids Res. 2022;50(W1):W210–W5. pmid:35610055; PubMed Central PMCID: PMC9252788.
  30. 30. van Kempen M, Kim SS, Tumescheit C, Mirdita M, Lee J, Gilchrist CLM, et al. Fast and accurate protein structure search with Foldseek. Nature Biotechnology. 2024;42(2):243–6. pmid:37156916
  31. 31. Fredriksson R, Lagerström MC, Lundin LG, Schiöth HB. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol. 2003;63(6):1256–72. pmid:12761335.
  32. 32. Lagerström MC, Schiöth HB. Structural diversity of G protein-coupled receptors and significance for drug discovery. Nature Reviews Drug Discovery. 2008;7(4):339–57. WOS:000254561500016. pmid:18382464
  33. 33. Krystofova S, Borkovich KA. The predicted G-protein-coupled receptor GPR-1 is required for female sexual development in the multicellular fungus Neurospora crassa. Eukaryot Cell. 2006;5(9):1503–16. pmid:16963633; PubMed Central PMCID: PMC1563582.
  34. 34. Li L, Borkovich KA. GPR-4 is a predicted G-protein-coupled receptor required for carbon source-dependent asexual growth and development in Neurospora crassa. Eukaryot Cell. 2006;5(8):1287–300. pmid:16896213; PubMed Central PMCID: PMC1539153.
  35. 35. Stauch B, Johansson LC, McCorvy JD, Patel N, Han GW, Huang XP, et al. Structural basis of ligand recognition at the human MT(1) melatonin receptor. Nature. 2019;569(7755):284–8. Epub 20190424. pmid:31019306; PubMed Central PMCID: PMC6696938.
  36. 36. Larrondo LF, Loros JJ, Dunlap JC. High-resolution spatiotemporal analysis of gene expression in real time: in vivo analysis of circadian rhythms in Neurospora crassa using a FREQUENCY-luciferase translational reporter. Fungal Genet Biol. 2012;49(9):681–3. Epub 20120610. pmid:22695169; PubMed Central PMCID: PMC3423521.
  37. 37. Baker CL, Loros JJ, Dunlap JC. The circadian clock of Neurospora crassa. Fems Microbiology Reviews. 2012;36(1):95–110. WOS:000298061900005. pmid:21707668
  38. 38. Grabowski M, Niedzialkowska E, Zimmerman MD, Minor W. The impact of structural genomics: the first quindecennial. Journal of Structural and Functional Genomics. 2016;17(1):1–16. pmid:26935210
  39. 39. Alföldi J, Lindblad-Toh K. Comparative genomics as a tool to understand evolution and disease. Genome Research. 2013;23(7):1063–8. pmid:23817047
  40. 40. Jobe A, Vijayan R. Orphan G protein-coupled receptors: the ongoing search for a home. Frontiers in Pharmacology. 2024;15. pmid:38495099
  41. 41. Kays AM, Rowley PS, Baasiri RA, Borkovich KA. Regulation of conidiation and adenylyl cyclase levels by the Galpha protein GNA-3 in Neurospora crassa. Mol Cell Biol. 2000;20(20):7693–705. pmid:11003665; PubMed Central PMCID: PMC86343.
  42. 42. Turner GE, Borkovich KA. Identification of a G protein alpha subunit from Neurospora crassa that is a member of the Gi family. J Biol Chem. 1993;268(20):14805–11. pmid:8325859.
  43. 43. Brydon L, Roka F, Petit L, de Coppet P, Tissot M, Barrett P, et al. Dual signaling of human Mel1a melatonin receptors via G(i2), G(i3), and G(q/11) proteins. Mol Endocrinol. 1999;13(12):2025–38. pmid:10598579.
  44. 44. Chen L, He X, Zhang Y, Chen X, Lai X, Shao J, et al. Melatonin receptor type 1 signals to extracellular signal-regulated kinase 1 and 2 via Gi and Gs dually coupled pathways in HEK-293 cells. Biochemistry. 2014;53(17):2827–39. Epub 20140421. pmid:24724723.
  45. 45. Harding SD, Armstrong JF, Faccenda E, Southan C, Alexander Stephen PH, Davenport AP, et al. The IUPHAR/BPS Guide to PHARMACOLOGY in 2024. Nucleic Acids Research. 2023;52(D1):D1438–D49. pmid:37897341
  46. 46. Mirdita M, Schutze K, Moriwaki Y, Heo L, Ovchinnikov S, Steinegger M. ColabFold: making protein folding accessible to all. Nat Methods. 2022;19(6):679–82. Epub 20220530. pmid:35637307; PubMed Central PMCID: PMC9184281.
  47. 47. Morgan LW, Greene AV, Bell-Pedersen D. Circadian and light-induced expression of luciferase in Neurospora crassa. Fungal Genetics and Biology. 2003;38(3):327–32. pmid:12684022
  48. 48. Lewy A. Clinical implications of the melatonin phase response curve. J Clin Endocrinol Metab. 2010;95(7):3158–60. pmid:20610608; PubMed Central PMCID: PMC2928905.
  49. 49. Kumar M, Hsiao K, Vidugiriene J, Goueli SA. A bioluminescent-based, HTS-compatible assay to monitor G-protein-coupled receptor modulation of cellular cyclic AMP. Assay Drug Dev Technol. 2007;5(2):237–45. pmid:17477832.
  50. 50. Saito H, Tamura M, Imai K, Ishigami T, Ochiai K. Catechin inhibits Candida albicans dimorphism by disrupting Cek1 phosphorylation and cAMP synthesis. Microb Pathog. 2013;56:16–20. Epub 20130118. pmid:23337884.